Remedy Pharmaceuticals' mission is to help people afflicted with central nervous system (CNS) related edema to not only survive, but live life to the fullest.
CNS related edema can affect people who experience large hemispheric infarction, traumatic brain injury, spinal cord injury, and a number of other CNS injuries and conditions, and in the process destroy lives, tear apart families, and cost healthcare systems billions of dollars. Sadly, little treatment is currently available for these victims, and where therapies do exist, many arrive at hospital outside the short time window needed to receive such care. Remedy’s drug CIRARA™ is designed to treat CNS related edema, lower mortality, improve patient lives, and reduce healthcare costs.
CIRARA is an investigational drug and is not approved for use. The safety and efficacy of CIRARA has not been established and is currently under investigation. CIRARA stories are presented to create awareness about CNS-related edema.
For more information on Remedy Pharmaceuticals or CIRARA, please CLICK HERE (Links to external site)